跳至主要内容
临床试验/EUCTR2008-006004-36-DK
EUCTR2008-006004-36-DK进行中(未招募)不适用

Efficacy and tolerability of captopril ointment 0,1%, 0,3% and 1,0% in psoriasis vulgaris. A randomised, double-blind, placebocontrolled, doseescalating, intra-individual clinical study

ACE ApS0 个研究点开始时间: 2008年11月4日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with psoriasis vulgaris
  • Age 18-80 (both included)
  • White (caucasian)
  • Normal weight
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Active psoriasis on test plaques reguiring dermatological treatment
  • Other skin disease (e.g. contact allegy, atopic dermatitis, urticaria)
  • Dermatological lighttreatment or use of solarium 4 weeks prior to the trial.
  • Start of systemic treatment prior to study start which can influence on the test plaques. Stabil systemic treatment started 4 month prior to study start are allowed as well as local treatment on other plaques than test plaques during the trial.
  • Known hypersensitivity to any constituents or active ingredients in the amounts present in the trial medication.
  • Known coronary heart disease.
  • Alcohol abuse or other type of abuse or dependency.
  • Participation in a clinical trial within 30 days prior to inclusion in this trial.
  • Lack of use of safe anticontraception.

研究者

发起方
ACE ApS

相似试验